Eagle Pharmaceuticals, Inc. Long-Term Debt, Maturity, Year Three
Eagle Pharmaceuticals, Inc. had Long-Term Debt, Maturity, Year Three of $0 as of 2023-06-30, per its 10-Q/A filed 2023-08-09.
Discontinued › Notes › Commitment and Contingencies › Long-Term Debt, Fiscal Year Maturity › Long-Term Debt, Maturity, Year Two and Three
us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree · last filed 2023-08-09
- 2023-06-30: Long-Term Debt, Maturity, Year Three $0.00.
- 2023-03-31: Long-Term Debt, Maturity, Year Three $0.00.
- 2022-12-31: Long-Term Debt, Maturity, Year Three $47.50M.
- 2022-09-30: Long-Term Debt, Maturity, Year Three $7.91M.
| Period end | Long-Term Debt, Maturity, Year Three |
|---|---|
| 2023-06-30 | $0.00 10-Q/A · filed 2023-08-09 |
| 2023-03-31 | $0.00 10-Q · filed 2023-05-09 |
| 2022-12-31 | $47.50M 10-K · filed 2023-03-23 |
| 2022-09-30 | $7.91M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $8.49M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-09 |
| 2021-12-31 | $0.00 10-K · filed 2022-03-08 |
| 2021-09-30 | $0.00 10-Q · filed 2021-11-09 |
| 2021-06-30 | $0.00 10-Q · filed 2021-08-09 |
| 2021-03-31 | $0.00 10-Q · filed 2021-05-10 |
| 2020-12-31 | $0.00 10-K · filed 2021-03-05 |
| 2020-09-30 | $0.00 10-Q · filed 2020-11-02 |
| 2020-06-30 | $0.00 10-Q · filed 2020-08-10 |
| 2020-03-31 | $26.00M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $26.00M 10-K · filed 2020-03-02 |
| 2019-09-30 | $8.00M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $0.00 10-Q · filed 2019-08-08 |
| 2019-03-31 | $33.75M 10-Q · filed 2019-05-07 |
| 2018-12-31 | $0.00 10-K · filed 2019-02-28 |
| 2018-09-30 | $38.75M 10-Q · filed 2018-11-01 |
| 2018-06-30 | $36.25M 10-Q · filed 2018-08-07 |
| 2018-03-31 | $38.75M 10-Q · filed 2018-05-10 |
| 2017-12-31 | $38.75M 10-K · filed 2018-02-26 |